Pfizer will buy NextWave Pharma for up to $700M
(AP)—Pfizer said Monday it will buy NextWave Pharmaceuticals Inc., a company that makes a liquid attention deficit hyperactivity disorder drug, in a deal worth as much as $700 million.
Oct 22, 2012
0
0